Which features predict mean survival of 6-12 months for myelodysplastic syndrome (MDS)?

Updated: Jul 24, 2018
  • Author: Emmanuel C Besa, MD; Chief Editor: Koyamangalath Krishnan, MD, FRCP, FACP  more...
  • Print

Mean survival is 6-12 months in patients with the following features:

  • Pancytopenia requiring red blood cell or platelet transfusions

  • Chromosome 7 abnormalities or multiple chromosomal abnormalities

  • Greater than 10% myeloblasts

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!